Show simple item record

dc.contributor.authorGroom, N
dc.contributor.authorWilson, E
dc.contributor.authorFaivre-Finn, Corinne
dc.date.accessioned2017-04-18T08:01:48Z
dc.date.available2017-04-18T08:01:48Z
dc.date.issued2017-03-31
dc.identifier.citationEffect of accurate heart delineation on cardiac dose during the CONVERT Trial. 2017, Br J Radiolen
dc.identifier.issn1748-880X
dc.identifier.pmid28362511
dc.identifier.doi10.1259/bjr.20170036
dc.identifier.urihttp://hdl.handle.net/10541/620240
dc.description.abstractThis study investigates the effect of deviation from protocol in heart delineation for the CONVERT Trial ( ClinicalTrials.gov Identifier NCT00433563) quality assurance (QA) programme, and the effect of that on mean cardiac dose and percentage of heart volume receiving ≥5Gy (V5%) and ≥30Gy (V30%).
dc.language.isoenen
dc.rightsArchived with thanks to The British journal of radiologyen
dc.titleEffect of accurate heart delineation on cardiac dose during the CONVERT Trial.en
dc.typeArticleen
dc.contributor.departmentMount Vernon Cancer Centre, Northwood, UKen
dc.identifier.journalThe British Journal of Radiologyen
html.description.abstractThis study investigates the effect of deviation from protocol in heart delineation for the CONVERT Trial ( ClinicalTrials.gov Identifier NCT00433563) quality assurance (QA) programme, and the effect of that on mean cardiac dose and percentage of heart volume receiving ≥5Gy (V5%) and ≥30Gy (V30%).


This item appears in the following Collection(s)

Show simple item record